
GlaxoSmithKline is to remove individual staff sales targets and end doctor payments for activities that promote its products. The UK …

Novartis is shutting down its manufacturing plant in Canada which will result in 300 people losing their jobs at the …

The healthcare division of comms agency giant Ketchum is weathering a tough month following job cuts and a key resignation. …

Forest Laboratories is restructuring and shedding jobs in a bid to save $500 million in costs by the end of …

Another 150 jobs are to go at Dendreon Corporation as the company seeks to cut $125 million per year in …

Rumours are growing that Shire will be cutting dozens of research posts at its R&D centre in Basingstoke, Hampshire. This …

Roche plans to invest a massive 800 million Swiss francs ($882m) over the next five years to increase manufacturing capacity …

The world’s largest generic drugmaker Teva will cut around 5,000 jobs from its global workforce as it looks to speed-up …


Swiss contract manufacturer Lonza has said it will start cutting staffing levels at its US facility in Hopkinton, Massachusetts, next …

Merck & Co has followed through with an earlier threat to close down its manufacturing operations at Kenilworth, New Jersey. …
Lundbeck is to cut yet more jobs in Europe as the Danish pharma firm restructures its operations to focus on …
Aveo will make major jobs cuts this year after news that a kidney cancer licence for its oncology drug tivozanib …

Teva has said it will shut down a manufacturing and R&D facility in Pennsylvania by 2017, with the loss of …
Roche is to cut around 170 jobs in Europe and the US as part of a restructure of its life …